Literature DB >> 22672880

Recent advances in imaging Alzheimer's disease.

Meredith N Braskie1, Arthur W Toga, Paul M Thompson.   

Abstract

Advances in brain imaging technology in the past five years have contributed greatly to the understanding of Alzheimer's disease (AD). Here, we review recent research related to amyloid imaging, new methods for magnetic resonance imaging analyses, and statistical methods. We also review research that evaluates AD risk factors and brain imaging, in the context of AD prediction and progression. We selected a variety of illustrative studies, describing how they advanced the field and are leading AD research in promising new directions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22672880      PMCID: PMC4110110          DOI: 10.3233/JAD-2012-129016

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  135 in total

1.  Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

Authors:  Victor L Villemagne; Kerryn E Pike; Gaël Chételat; Kathryn A Ellis; Rachel S Mulligan; Pierrick Bourgeat; Uwe Ackermann; Gareth Jones; Cassandra Szoeke; Olivier Salvado; Ralph Martins; Graeme O'Keefe; Chester A Mathis; William E Klunk; David Ames; Colin L Masters; Christopher C Rowe
Journal:  Ann Neurol       Date:  2011-01       Impact factor: 10.422

2.  Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.

Authors:  Jonathan H Morra; Zhuowen Tu; Liana G Apostolova; Amity E Green; Christina Avedissian; Sarah K Madsen; Neelroop Parikshak; Arthur W Toga; Clifford R Jack; Norbert Schuff; Michael W Weiner; Paul M Thompson
Journal:  Neuroimage       Date:  2008-11-08       Impact factor: 6.556

3.  Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly.

Authors:  Anne M Fagan; Denise Head; Aarti R Shah; Daniel Marcus; Mark Mintun; John C Morris; David M Holtzman
Journal:  Ann Neurol       Date:  2009-02       Impact factor: 10.422

4.  Identifying cognitively healthy elderly individuals with subsequent memory decline by using automated MR temporoparietal volumes.

Authors:  Gloria C Chiang; Philip S Insel; Duygu Tosun; Norbert Schuff; Diana Truran-Sacrey; Sky Raptentsetsang; Clifford R Jack; Michael W Weiner
Journal:  Radiology       Date:  2011-04-05       Impact factor: 11.105

5.  Heritability for Alzheimer's disease: the study of dementia in Swedish twins.

Authors:  M Gatz; N L Pedersen; S Berg; B Johansson; K Johansson; J A Mortimer; S F Posner; M Viitanen; B Winblad; A Ahlbom
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1997-03       Impact factor: 6.053

6.  Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's.

Authors:  Lisa Mosconi; Lidia Glodzik; Rachel Mistur; Pauline McHugh; Kenneth E Rich; Elizabeth Javier; Schantel Williams; Elizabeth Pirraglia; Susan De Santi; Pankaj D Mehta; Raymond Zinkowski; Kaj Blennow; Domenico Pratico; Mony J de Leon
Journal:  Biol Psychiatry       Date:  2010-11-15       Impact factor: 13.382

7.  Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain.

Authors:  Seok Rye Choi; Geoff Golding; Zhiping Zhuang; Wei Zhang; Nathaniel Lim; Franz Hefti; Tyler E Benedum; Michael R Kilbourn; Daniel Skovronsky; Hank F Kung
Journal:  J Nucl Med       Date:  2009-10-16       Impact factor: 10.057

8.  Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease.

Authors:  Natalie Nelissen; Koen Van Laere; Lennart Thurfjell; Rikard Owenius; Mathieu Vandenbulcke; Michel Koole; Guy Bormans; David J Brooks; Rik Vandenberghe
Journal:  J Nucl Med       Date:  2009-07-17       Impact factor: 10.057

9.  Amyloid deposition is associated with impaired default network function in older persons without dementia.

Authors:  Reisa A Sperling; Peter S Laviolette; Kelly O'Keefe; Jacqueline O'Brien; Dorene M Rentz; Maija Pihlajamaki; Gad Marshall; Bradley T Hyman; Dennis J Selkoe; Trey Hedden; Randy L Buckner; J Alex Becker; Keith A Johnson
Journal:  Neuron       Date:  2009-07-30       Impact factor: 17.173

10.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Authors:  Adam C Naj; Gyungah Jun; Gary W Beecham; Li-San Wang; Badri Narayan Vardarajan; Jacqueline Buros; Paul J Gallins; Joseph D Buxbaum; Gail P Jarvik; Paul K Crane; Eric B Larson; Thomas D Bird; Bradley F Boeve; Neill R Graff-Radford; Philip L De Jager; Denis Evans; Julie A Schneider; Minerva M Carrasquillo; Nilufer Ertekin-Taner; Steven G Younkin; Carlos Cruchaga; John S K Kauwe; Petra Nowotny; Patricia Kramer; John Hardy; Matthew J Huentelman; Amanda J Myers; Michael M Barmada; F Yesim Demirci; Clinton T Baldwin; Robert C Green; Ekaterina Rogaeva; Peter St George-Hyslop; Steven E Arnold; Robert Barber; Thomas Beach; Eileen H Bigio; James D Bowen; Adam Boxer; James R Burke; Nigel J Cairns; Chris S Carlson; Regina M Carney; Steven L Carroll; Helena C Chui; David G Clark; Jason Corneveaux; Carl W Cotman; Jeffrey L Cummings; Charles DeCarli; Steven T DeKosky; Ramon Diaz-Arrastia; Malcolm Dick; Dennis W Dickson; William G Ellis; Kelley M Faber; Kenneth B Fallon; Martin R Farlow; Steven Ferris; Matthew P Frosch; Douglas R Galasko; Mary Ganguli; Marla Gearing; Daniel H Geschwind; Bernardino Ghetti; John R Gilbert; Sid Gilman; Bruno Giordani; Jonathan D Glass; John H Growdon; Ronald L Hamilton; Lindy E Harrell; Elizabeth Head; Lawrence S Honig; Christine M Hulette; Bradley T Hyman; Gregory A Jicha; Lee-Way Jin; Nancy Johnson; Jason Karlawish; Anna Karydas; Jeffrey A Kaye; Ronald Kim; Edward H Koo; Neil W Kowall; James J Lah; Allan I Levey; Andrew P Lieberman; Oscar L Lopez; Wendy J Mack; Daniel C Marson; Frank Martiniuk; Deborah C Mash; Eliezer Masliah; Wayne C McCormick; Susan M McCurry; Andrew N McDavid; Ann C McKee; Marsel Mesulam; Bruce L Miller; Carol A Miller; Joshua W Miller; Joseph E Parisi; Daniel P Perl; Elaine Peskind; Ronald C Petersen; Wayne W Poon; Joseph F Quinn; Ruchita A Rajbhandary; Murray Raskind; Barry Reisberg; John M Ringman; Erik D Roberson; Roger N Rosenberg; Mary Sano; Lon S Schneider; William Seeley; Michael L Shelanski; Michael A Slifer; Charles D Smith; Joshua A Sonnen; Salvatore Spina; Robert A Stern; Rudolph E Tanzi; John Q Trojanowski; Juan C Troncoso; Vivianna M Van Deerlin; Harry V Vinters; Jean Paul Vonsattel; Sandra Weintraub; Kathleen A Welsh-Bohmer; Jennifer Williamson; Randall L Woltjer; Laura B Cantwell; Beth A Dombroski; Duane Beekly; Kathryn L Lunetta; Eden R Martin; M Ilyas Kamboh; Andrew J Saykin; Eric M Reiman; David A Bennett; John C Morris; Thomas J Montine; Alison M Goate; Deborah Blacker; Debby W Tsuang; Hakon Hakonarson; Walter A Kukull; Tatiana M Foroud; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg
Journal:  Nat Genet       Date:  2011-04-03       Impact factor: 38.330

View more
  14 in total

Review 1.  Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings.

Authors:  Meredith N Braskie; Paul M Thompson
Journal:  Trends Cogn Sci       Date:  2013-09-09       Impact factor: 20.229

2.  The use of metacognitive strategies to decrease false memories in source monitoring in patients with mild cognitive impairment.

Authors:  Rebecca G Deason; Neil A Nadkarni; Michelle J Tat; Sean Flannery; Bruno Frustace; Brandon A Ally; Andrew E Budson
Journal:  Cortex       Date:  2017-02-03       Impact factor: 4.027

3.  Heritability of hippocampal subfield volumes using a twin and non-twin siblings design.

Authors:  Sejal Patel; Min Tae M Park; Gabriel A Devenyi; Raihaan Patel; Mario Masellis; Jo Knight; M Mallar Chakravarty
Journal:  Hum Brain Mapp       Date:  2017-05-31       Impact factor: 5.038

4.  The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer's disease.

Authors:  Leah H Rubin; Erin E Sundermann; David J Moore
Journal:  J Neurovirol       Date:  2019-01-22       Impact factor: 2.643

5.  Genome-wide interaction analysis reveals replicated epistatic effects on brain structure.

Authors:  Derrek P Hibar; Jason L Stein; Neda Jahanshad; Omid Kohannim; Xue Hua; Arthur W Toga; Katie L McMahon; Greig I de Zubicaray; Nicholas G Martin; Margaret J Wright; Michael W Weiner; Paul M Thompson
Journal:  Neurobiol Aging       Date:  2014-08-27       Impact factor: 4.673

6.  Response bias and response monitoring: Evidence from healthy older adults and patients with mild Alzheimer's disease.

Authors:  Rebecca G Deason; Michelle J Tat; Sean Flannery; Prabhakar S Mithal; Erin P Hussey; Eileen T Crehan; Brandon A Ally; Andrew E Budson
Journal:  Brain Cogn       Date:  2017-09-17       Impact factor: 2.310

7.  Automated Detection of Alzheimer's Disease Using Brain MRI Images- A Study with Various Feature Extraction Techniques.

Authors:  U Rajendra Acharya; Steven Lawrence Fernandes; Joel En WeiKoh; Edward J Ciaccio; Mohd Kamil Mohd Fabell; U John Tanik; V Rajinikanth; Chai Hong Yeong
Journal:  J Med Syst       Date:  2019-08-09       Impact factor: 4.460

8.  A Computational Monte Carlo Simulation Strategy to Determine the Temporal Ordering of Abnormal Age Onset Among Biomarkers of Alzheimer's Disease.

Authors:  Xiaojuan Guo; Kewei Chen; Yinghua Chen; Chengjie Xiong; Yi Su; Li Yao; Eric M Reiman
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2022-10-10       Impact factor: 3.702

Review 9.  A focus on structural brain imaging in the Alzheimer's disease neuroimaging initiative.

Authors:  Meredith N Braskie; Paul M Thompson
Journal:  Biol Psychiatry       Date:  2013-11-28       Impact factor: 13.382

10.  A blood based 12-miRNA signature of Alzheimer disease patients.

Authors:  Petra Leidinger; Christina Backes; Stephanie Deutscher; Katja Schmitt; Sabine C Mueller; Karen Frese; Jan Haas; Klemens Ruprecht; Friedemann Paul; Cord Stähler; Christoph J G Lang; Benjamin Meder; Tamas Bartfai; Eckart Meese; Andreas Keller
Journal:  Genome Biol       Date:  2013-07-29       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.